Difference between revisions of "WSI23-10-Case-8"

From MGH Learn Pathology
(Added status template)
 
(2 intermediate revisions by 2 users not shown)
Line 11: Line 11:
 
|requester=Aja51
 
|requester=Aja51
 
|locationCode=learn
 
|locationCode=learn
|sequence=8
+
|sequence=7
 
|performer=RH27
 
|performer=RH27
 
|bodySite=BONE MARROW BIOPSY
 
|bodySite=BONE MARROW BIOPSY
|reasonCode=68 year old man with history of MDS on luspatercept
+
|reasonCode=68 year old man with history of MDS on luspatercept.
|supportingInfo=MDS with RS and erythroid predominance (MDS with mutated SF3B1).
+
|supportingInfo=MDS with RS and erythroid predominance (MDS with mutated SF3B1).  WBC 2.7 (41% polys, 2% bands, 40% lymphs, 11% monos, 2% eos, 4% basos), HGB 7.3, MCV 94.6, PLT 420.
 
}}
 
}}
 
{{Media
 
{{Media
Line 46: Line 46:
 
|view=show
 
|view=show
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Aja51
 +
|authoredOn=February 03, 2023 01:48:03 PM
 
}}
 
}}

Latest revision as of 14:43, December 9, 2024

WSI23-10-Case-8
68 year old man with history of MDS on luspatercept.
MDS with RS and erythroid predominance (MDS with mutated SF3B1). WBC 2.7 (41% polys, 2% bands, 40% lymphs, 11% monos, 2% eos, 4% basos), HGB 7.3, MCV 94.6, PLT 420.
April 6, 2023 12:00:00 AM